Opening book details…
About this book
Complementation Dependent Enzyme Prodrug Therapy Enables Targeted Activation of Prodrug on HER2-Positive Cancer Cells by Christine S. Nervig, Samuel T. Hatch & Shawn C. Owen is a book available to read on EtoBox.
- Author
- Christine S. Nervig, Samuel T. Hatch & Shawn C. Owen
- Published
- 2022
- Language
- EN
More by Christine S. Nervig, Samuel T. Hatch & Shawn C. Owen
Browse all works by Christine S. Nervig, Samuel T. Hatch & Shawn C. Owen
Similar books
- Selective Cyclin-Dependent Kinase Inhibitors and Their Application in Cancer Therapy — Robert B. Kargbo (2022)
- Combination of Cyclin-Dependent Kinase 4 Inhibitors and Androgen Receptor Inhibitors as Cancer Therapy — Ahmed F. Abdel-Magid (2022)
- Enzyme-Prodrug Strategies for Cancer Therapy — Richard J. Knox, Roger G. Melton (auth.), (1999)
- Potential of Cyclin-Dependent Kinase Inhibitors as Cancer Therapy — Ahmed F. Abdel-Magid (2021)
- Tumor-Targeted Bivalent Protein Degradation for Application in Cancer Therapy — Robert B. Kargbo (2021)
- Tumor-targeted PROTAC Prodrug Nanoplatform Enables Precise Protein Degradation and Combination Cancer Therapy — Zhi-feng Zou & Lei Yang & Hui-jun Nie & Jing Gao & Shu-min Lei & Yi Lai & Fan Zhang & Ernst Wagner & Hai-jun Yu & Xiao-hua Chen & Zhi-ai Xu (2024)